Morning Overview on MSN
AstraZeneca says Ultomiris cut urine protein in late-stage kidney trial
AstraZeneca announced in May 2026 that its drug Ultomiris significantly reduced urine protein levels in patients with IgA ...
The 2026 NFL Draft is underway. Months of scouting, planning and -- for some teams -- aggressive trading led to these three ...
20hon MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
This three-month, double-blind, randomized (1:1), placebo-controlled trial evaluated whether individualized homeopathic medicinal products (IHMPs) are superior to placebo in reducing anorectal symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results